Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
Won Jin Ho, Elizabeth M. Jaffee, Lei Zheng
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 9, pp. 527-540
Open Access | Times Cited: 881

Showing 26-50 of 881 citing articles:

Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
Keyu Li, Joseph A. Tandurella, Jessica Gai, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1374-1391.e7
Open Access | Times Cited: 94
Reactive oxygen species-powered cancer immunotherapy: Current status and challenges
Mengying He, Mengyuan Wang, Tao Xu, et al.
Journal of Controlled Release (2023) Vol. 356, pp. 623-648
Closed Access | Times Cited: 89
A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
Riya Thapa, Gaurav Gupta, Asif Ahmad Bhat, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127375-127375
Closed Access | Times Cited: 88
Uridine-derived ribose fuels glucose-restricted pancreatic cancer
Zeribe C. Nwosu, Matthew H. Ward, Peter Sajjakulnukit, et al.
Nature (2023) Vol. 618, Iss. 7963, pp. 151-158
Open Access | Times Cited: 83
Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer
Madeleine M. LaRue, Seth J. Parker, Joseph Puccini, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 16
Open Access | Times Cited: 76
Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling
Barath Udayasuryan, Raffae N. Ahmad, Tam T. D. Nguyen, et al.
Science Signaling (2022) Vol. 15, Iss. 756
Open Access | Times Cited: 76
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Qiaofei Liu, Jiayi Li, Huaijin Zheng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
Loretah Chibaya, Katherine Murphy, Kelly D. DeMarco, et al.
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 872-892
Open Access | Times Cited: 58
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
Yifan Liu, Yansha Sun, Peng Wang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 53
Microneedle Patch Integrated with Porous Silicon Confined Dual Nanozymes for Synergistic and Hyperthermia‐Enhanced Nanocatalytic Ferroptosis Treatment of Melanoma
Jingwen Zhao, Wei Duan, Xingyue Liu, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 47
Open Access | Times Cited: 47
Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma
Xin Zhang, Jinke Zhuge, Jinhui Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 46
Peptide Drug Conjugates and Their Role in Cancer Therapy
Ethan Heh, Jesse Allen, Fabiola Ramirez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 829-829
Open Access | Times Cited: 45
Targeting pancreatic cancer metabolic dependencies through glutamine antagonism
Joel Encarnación-Rosado, Albert S.W. Sohn, Douglas E. Biancur, et al.
Nature Cancer (2023) Vol. 5, Iss. 1, pp. 85-99
Open Access | Times Cited: 44
CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma
Xiaomeng Liu, Rong Tang, Jin Xu, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2329-2343
Open Access | Times Cited: 43
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development
Tadahito Yasuda, Yanru Wang
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 627-642
Open Access | Times Cited: 30
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
Marc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1859-1877
Closed Access | Times Cited: 29
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Pancreatic cancer environment: from patient-derived models to single-cell omics
Ao Gu, Jiatong Li, Shimei Qiu, et al.
Molecular Omics (2024) Vol. 20, Iss. 4, pp. 220-233
Closed Access | Times Cited: 24
Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy
Chengming Qu, Haitao Yuan, Ming Tian, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4019-4037
Closed Access | Times Cited: 23
Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance
Xiaozhen Zhang, Mengyi Lao, Hanshen Yang, et al.
Autophagy (2024) Vol. 20, Iss. 6, pp. 1314-1334
Open Access | Times Cited: 21
Roles of microbiota in pancreatic cancer development and treatment
Mariana Santos Cruz, Joseph Tintelnot, Nicola Gagliani
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 21
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers
Aurélien Voissière, Carlos Gomez‐Roca, Sylvie Chabaud, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Closed Access | Times Cited: 18
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 17
Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer
Ziyi Han, Zhuang-Jiong Fu, Yu‐Zhang Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16

Scroll to top